全文获取类型
收费全文 | 2766篇 |
免费 | 181篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 55篇 |
妇产科学 | 34篇 |
基础医学 | 399篇 |
口腔科学 | 90篇 |
临床医学 | 265篇 |
内科学 | 427篇 |
皮肤病学 | 34篇 |
神经病学 | 251篇 |
特种医学 | 137篇 |
外科学 | 577篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 211篇 |
眼科学 | 92篇 |
药学 | 179篇 |
中国医学 | 4篇 |
肿瘤学 | 175篇 |
出版年
2023年 | 16篇 |
2022年 | 61篇 |
2021年 | 121篇 |
2020年 | 53篇 |
2019年 | 65篇 |
2018年 | 72篇 |
2017年 | 83篇 |
2016年 | 91篇 |
2015年 | 81篇 |
2014年 | 137篇 |
2013年 | 153篇 |
2012年 | 221篇 |
2011年 | 222篇 |
2010年 | 135篇 |
2009年 | 106篇 |
2008年 | 181篇 |
2007年 | 188篇 |
2006年 | 163篇 |
2005年 | 156篇 |
2004年 | 140篇 |
2003年 | 138篇 |
2002年 | 115篇 |
2001年 | 22篇 |
2000年 | 12篇 |
1999年 | 17篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 11篇 |
1995年 | 6篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 10篇 |
1987年 | 8篇 |
1986年 | 17篇 |
1985年 | 10篇 |
1984年 | 13篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1979年 | 4篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1971年 | 7篇 |
1970年 | 9篇 |
1969年 | 4篇 |
1968年 | 7篇 |
排序方式: 共有2971条查询结果,搜索用时 31 毫秒
71.
72.
Recorded psychiatric comorbidity with bipolar disorder – A Finnish hospital discharge register study
Bipolar disorder is frequently connected to other psychiatric disorders. On the basis of The National Hospital Discharge Register in Finland, we studied the recorded prevalence of psychiatric comorbidity among bipolar inpatients by clinicians, and the factors that were associated with it. Of the 2687 hospital stays in 1998, 82% had no other recorded psychiatric diagnosis except an episode of bipolar disorder. Psychiatric comorbidity was recorded in 18% of hospital stays, of which 20% had two comorbid psychiatric diagnoses. Substance-related disorders (11%) were the most commonly recorded comorbid disorders. Personality disorders were recorded in 6%, and anxiety disorder in 1% of the hospital stays. These figures should be considered far below the expected ones. Recorded comorbidity was associated with the type of episode. Comorbidity in bipolar disorder in psychiatric hospitals in Finland seems to go greatly undetected and may have a deteriorating impact on the course of the illness. 相似文献
73.
Gazanfar Rahmathulla Nicholas F. Marko Robert J. Weil 《Journal of clinical neuroscience》2013,20(4):485-502
Radiation therapy forms one of the building blocks of the multi-disciplinary management of patients with brain tumors. Improved survival following radiation therapy may come with a cost, including the potential complication of radiation necrosis. Radiation necrosis impacts the quality of life in cancer survivors, and it is essential to detect and effectively treat this entity as early as possible.Significant progress in neuro-radiology and molecular pathology facilitate more straightforward diagnosis and characterization of cerebral radiation necrosis. Several therapeutic interventions, both medical and surgical, may halt the progression of radiation necrosis and diminish or abrogate its clinical manifestations, but there are still no definitive guidelines to follow explicitly that guide treatment of radiation necrosis. We discuss the pathobiology, clinical features, diagnosis, available treatment modalities, and outcomes in the management of patients with intracranial radiation necrosis that follows radiation used to treat brain tumors. 相似文献
74.
Juhani Ojala Jukka Vanhanen Hanna Harno Pantelis Lioumis Selja Vaalto Mari A. Kaunisto Jukka Putaala Marko Kangasniemi Erika Kirveskari Jyrki P. Mäkelä Eija Kalso 《Neuromodulation》2022,25(4):538-548
ObjectivesCentral poststroke pain (CPSP), a neuropathic pain condition, is difficult to treat. Repetitive transcranial magnetic stimulation (rTMS) targeted to the primary motor cortex (M1) can alleviate the condition, but not all patients respond. We aimed to assess a promising alternative rTMS target, the secondary somatosensory cortex (S2), for CPSP treatment.Materials and MethodsThis prospective, randomized, double-blind, sham-controlled three-arm crossover trial assessed navigated rTMS (nrTMS) targeted to M1 and S2 (10 sessions, 5050 pulses per session at 10 Hz). Participants were evaluated for pain, depression, anxiety, health-related quality of life, upper limb function, and three plasticity-related gene polymorphisms including Dopamine D2 Receptor (DRD2). We monitored pain intensity and interference before and during stimulations and at one month. A conditioned pain modulation test was performed using the cold pressor test. This assessed the efficacy of the descending inhibitory system, which may transmit TMS effects in pain control.ResultsWe prescreened 73 patients, screened 29, and included 21, of whom 17 completed the trial. NrTMS targeted to S2 resulted in long-term (from baseline to one-month follow-up) pain intensity reduction of ≥30% in 18% (3/17) of participants. All stimulations showed a short-term effect on pain (17–20% pain relief), with no difference between M1, S2, or sham stimulations, indicating a strong placebo effect. Only nrTMS targeted to S2 resulted in a significant long-term pain intensity reduction (15% pain relief). The cold pressor test reduced CPSP pain intensity significantly (p = 0.001), indicating functioning descending inhibitory controls. The homozygous DRD2 T/T genotype is associated with the M1 stimulation response.ConclusionsS2 is a promising nrTMS target in the treatment of CPSP. The DRD2 T/T genotype might be a biomarker for M1 nrTMS response, but this needs confirmation from a larger study. 相似文献
75.
76.
77.
78.
Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for ST-elevation acute myocardial infarction (STEMI). In comatose survivors of cardiac arrest, mild induced hypothermia (MIH) improves neurological recovery. In the present study, we investigated feasibility and safety of combining primary PCI and MIH in comatose survivors of ventricular fibrillation with signs of STEMI after reestablishment of spontaneous circulation. Forty consecutive patients undergoing primary PCI and MIH from November 1, 2003 to December 31, 2005 were compared to 32 consecutive patients who underwent primary PCI but no MIH between January 1, 2000 and November 1, 2003. There were no significant differences between the MIH and no MIH groups in general characteristics, cardiac arrest circumstances and angiographic features. Except for decreases in heart rate during hypothermia interval, there was no difference between the MIH and no MIH groups in arterial pressure, peak arterial lactate (5.1 mmol/l versus 5.7 mmol/l; p = .56), need for vasopressors (65% versus 53%; p = .44), inotropes (48% versus 59%; p = .44), aortic balloon counterpulsation (20% versus 22%; p = .92), repeat cardioversion/defibrillation (30% versus 34%; p=.89) and use of antiarrhythmics (33% versus 53%; p = .13). There was also no difference in inspired oxygen requirements during mechanical ventilation and in renal function. Hospital survival with cerebral performance category 1 and 2 was significantly better in MIH group (55% versus 16%; p=.001). Our preliminary experience indicates that primary PCI and MIH are feasible and may be combined safely in comatose survivors of ventricular fibrillation with signs of STEMI. Such a strategy may improve survival with good neurological recovery. 相似文献
79.
80.